Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A team of experts at NDM’s Pandemic Sciences Institute and the Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalisations and 9,600 deaths during its first year.

The new research, published today in Nature Communications, is the most comprehensive evaluation of the NHS COVID-19 contact tracing app to date.  

Researchers analysed the NHS COVID-19 app in England and Wales in the first year of its use – September 2020 to September 2021. They found that the app played an important role in reducing the transmission of COVID-19 in England and Wales. The app experienced high user engagement, identified infectious contacts well, and helped to prevent significant numbers of cases, hospitalisations and deaths. 

Professor Christophe Fraser, Principle Investigator at the Pandemic Sciences Institute at the University of Oxford’s Nuffield Department of Medicine and the paper’s senior author said: “Many of us will remember being ‘pinged’ by the NHS COVID-19 app at the height of the pandemic, and the impact that self-isolating had on our daily lives. Our research shows that the NHS COVID-19 app worked, and it worked well. Through our analysis, we estimate the app saved almost 10,000 lives in its first year alone.

“The app prevented people from transmitting the virus by generating notifications that they had been exposed to confirmed cases. The app’s effectiveness improved over time, particularly as rapid testing became more widely adopted, reducing the need for people to self-isolate following a ‘ping’. We find that digital contact tracing, a relatively low-cost and rapidly available intervention is a valuable public health measure for reducing transmission in any future epidemic waves of COVID-19 or similar viruses.”  

Dr Michelle Kendall, Research Fellow in the Department of Statistics at the University of Warwick and the paper’s first author said: “Due to the privacy-preserving design of the app, a user who entered their positive test result and agreed to anonymously notify their contacts cannot know the individual impact of their actions. 
 
“Nevertheless, our research shows that the app was successful in quickly alerting people at high risk of having been infected. Collectively, the millions of users in England and Wales who engaged with the app and followed the guidance of its notifications helped to substantially reduce case numbers, reduced pressure on the NHS, and saved lives.”   

The NHS COVID-19 app was launched in England and Wales on 24 September 2020, with over 10 million people installing it in the first few days. Although app use varied over time and across the country, the app remained popular throughout its first year, with a high proportion of people using it compared to similar apps across Europe. 

The app worked by using Google and Apple’s Bluetooth contact tracing function to reduce transmission of SARS-CoV-2, the virus that causes COVID-19. The app quickly notified people at higher risk of having been infected, so that they could reduce their chances of passing on an infection. The research found that all times, an app notification meant you were at least twice as likely to be infected as a non-notified app user, and at peak times this was as high as 77 times more likely. 

Dr Isabel Oliver, Chief Scientific Officer at UK Health Security Agency said: “The NHS COVID-19 app is a really practical example of how modern technology can be used to protect the nation’s health and the economy during a pandemic, by letting people know if they had been in contact with a positive case of COVID-19 and providing advice to help reduce the risk of passing the virus on to other people. 

“These findings indicate that the app made a key contribution to breaking the chains of transmission with an estimated 1 million cases, 44,000 hospitalisations, and 9,600 deaths prevented in the first year. 

“We’ve consolidated the skills, technology and lessons of NHS Test and Trace, such as the potential applications of a contract tracing mobile app, into the UK Health Security Agency to inform preparedness for future pandemic threats. Our learnings from the pandemic continue to shape how we, and our partners around the world, respond to future public health risks.”

The study adds to the growing body of evidence that shows digital contact tracing apps have major potential for reducing transmission of COVID-19 when combined with strong user engagement.

Similar stories

Building the world's evidence base to tackle drug-resistant tuberculosis

£10 million international research programme launches across India, Kazakhstan, Mozambique, South Africa and Vietnam.

A New Layer of Control for a Decades-Old Leukemia Drug

How cells respond to the leukemia drug 6-thioguanine still holds surprises: A new study, led jointly by researchers from CeMM and the University of Oxford identifies NUDT5 as an unexpected regulator of drug sensitivity and reveals that its role has nothing to do with its enzymatic activity.

Team ATLAS sets out strategy to investigate cancer avoidance as part of Cancer Grand Challenges

A new position paper from team ATLAS sets out plans to build a cancer antibody atlas to investigate why some people avoid cancer, while others develop disease.

Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease

Scientists have identified the missing link between a long-known genetic signal in inflammatory bowel disease and a damaging immune response that switches off the body’s natural control of inflammation - opening the door to faster diagnosis and targeted treatment.

Oxford Bundibugyo ebolavirus vaccine candidate receives CEPI backing

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced today that it will urgently accelerate the development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda, including one being developed by the Oxford Vaccine Group at the University of Oxford.

New study improves early detection of life threatening infection in children across South and South East Asia

A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.